Asia-Pacific Americas Africa Europe Middle East

ZYDUS HOSPIRA ONCOLOGY PVT LTD

Company Profile:

Company Introduction:

Zydus Hospira Oncology Pvt Ltd was a prominent entity in the Indian pharmaceutical sector, dedicated to the development, manufacturing, and marketing of oncology products. It originated as a 50:50 joint venture between Zydus Lifesciences, formerly known as Cadila Healthcare Ltd, a leading Indian pharmaceutical company, and Hospira Inc., a global leader in injectable drugs and infusion technologies, which was subsequently acquired by Pfizer.

The company's core focus was on a diverse portfolio of injectable oncology formulations. It aimed to address the increasing need for advanced cancer treatments within India and for export to other international markets. Its operations comprehensively included robust research and development activities, the operation of advanced manufacturing facilities adhering to stringent quality standards, and the establishment of an efficient distribution network for its specialized product offerings. This collaborative venture effectively combined Zydus's strong domestic market presence and R&D prowess with Hospira's extensive global expertise in sterile injectables and the oncology therapeutic area.

In a significant strategic development in 2017, Zydus Lifesciences completed the acquisition of Hospira's 50 percent stake in the joint venture. Consequently, Zydus Hospira Oncology Pvt Ltd transitioned to become a wholly-owned subsidiary of Zydus Lifesciences, further strengthening Zydus's leadership in the oncology segment.

Factory or Trader:

Zydus Hospira Oncology Pvt Ltd primarily operates as a manufacturer.

Enterprise Products

ZYDUS HOSPIRA ONCOLOGY PVT LTD

Products Manufactured or Sold:

Cytotoxic Chemotherapy Agents:

Paclitaxel

Docetaxel

Gemcitabine

Pemetrexed

Capecitabine

Carboplatin

Cisplatin

Oxaliplatin

Irinotecan

Etoposide

Cyclophosphamide

Ifosfamide

5-Fluorouracil (5-FU)

Targeted Therapies and Kinase Inhibitors:

Gefitinib

Erlotinib

Imatinib

Sunitinib

Sorafenib

Dasatinib

Nilotinib

Bortezomib

Lenalidomide

Hormonal Therapies:

Letrozole

Anastrozole

Tamoxifen

Goserelin

Leuprolide

Business Registration Information:

Manager:

Sharvil Pankajbhai Patel

Phone:

+91 79 26868100

E-mail:

info@zyduslife.com

Official Website:
Address:

Zydus Corporate Park, Scheme No. 6, Sarkhej-Bavla N.H. No. 8A, Ahmedabad - 382210, Gujarat, India

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.